Ironwood Pharmaceuti (IRWD) Stock Price, Quote & News

Company Profile

Ironwood Pharmaceuticals, Inc., a biotechnology company, focuses on the development and commercialization of therapies for gastrointestinal (GI) and rare diseases in the United States and internationally. It markets linaclotide, a guanylate cyclase type-C (GC-C) agonist for the treatment of adults suffering from irritable bowel syndrome with constipation or chronic idiopathic constipation, as well as for pediatric patients suffering from functional constipation under the LINZESS and CONSTELLA na...

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 617 621 7722

Fax: 617 494 0480

Website: ironwoodpharma.com

Address:

100 Summer Street, Suite 2300, Boston, United States

VSTN Jun. 26 at 5:16 PM

$IRWD Not sure where this is going, but it’s worth buying a little. At this point it can only go to zero. I don’t know what they can get for this company, if anything

0 · Reply

Green_dillo Jun. 26 at 4:15 PM

$IRWD 👀👀

0 · Reply

Peterson28 Jun. 26 at 1:40 AM

$IRWD No one is selling. Only one reason for that.

1 · Reply

BluntForceOptions Jun. 25 at 9:15 PM

$IRWD Sub-$1 sure feels like it’s on borrowed time.

0 · Reply

RunnerSignals Jun. 25 at 8:21 PM

comeback kings in action! $CTKB $CDTX $IRWD $UEC $MXCT hit lows but closed strong, proving every dip can spark a big bounce

0 · Reply

Estimize Jun. 25 at 7:05 PM

Wall St is expecting 0.04 EPS for $IRWD Q2 [Reporting 08/07 BMO] http://www.estimize.com/intro/irwd?chart=historical&metric_name=eps&utm_co

0 · Reply

valueforme Jun. 25 at 7:04 PM

$IRWD Very patient accumulation

0 · Reply

Mau74 Jun. 25 at 4:32 PM

$IRWD no volume no party

0 · Reply

Winning_calls Jun. 25 at 3:54 PM

$IRWD 😉

1 · Reply

Peterson28 Jun. 25 at 2:57 PM

$IRWD Only $100K trade for 90mins since open. What is happening?

1 · Reply

Ironwood Pharmaceuticals Reports First Quarter 2025 Results

Apr 30, 2025, 4:25 PM EDT - 2 months ago

Ironwood Pharmaceuticals to Participate in The Citizens Life Sciences Conference

Apr 25, 2025, 7:05 AM EDT - 2 months ago

Ironwood Pharmaceuticals Reiterates Full-Year 2025 LINZESS U.S. Net Sales Guidance and Raises Adjusted EBITDA Guidance

Apr 22, 2025, 4:05 PM EDT - 2 months ago

Ironwood Pharmaceuticals to Present Real-World Data at Digestive Disease Week® 2025 on Adoption of New Diagnosis Codes Among Short Bowel Syndrome Patients Who Are Dependent on Parenteral Support

Apr 14, 2025, 2:19 PM EDT - 2 months ago

Ironwood Pharmaceuticals Stock Plunges, FDA Wants Another Trial For Gastrointestinal Drug

Apr 14, 2025, 7:00 AM EDT - 2 months ago

Ironwood Pharmaceuticals Provides Clinical and Regulatory Update on Apraglutide

Apr 10, 2025, 10:49 AM EDT - 2 months ago

Ironwood Pharmaceuticals: Setting A Strong Foundation For A Return To Growth

Mar 27, 2025, 4:05 PM EDT - 3 months ago

Ironwood Pharmaceuticals Announces Receipt of Nasdaq Non-Compliance Notification Regarding Late 2024 Form 10-K Filing

Mar 25, 2025, 8:30 AM EDT - 3 months ago

Industry Veteran Launches Ironwood III With Substantial Equity Commitment From Kayne Anderson Energy Infrastructure Fund

Feb 27, 2025, 11:21 AM EST - 4 months ago

Ironwood Pharmaceuticals, Inc. (IRWD) Q4 2024 Earnings Call Transcript

Feb 27, 2025, 7:00 AM EST - 4 months ago

Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Results; Achieves 2024 Financial Guidance

Feb 20, 2025, 4:00 PM EST - 4 months ago

Ironwood Pharmaceuticals to Host Fourth Quarter and Full Year 2024 Investor Update Call

Jan 29, 2025, 4:05 PM EST - 5 months ago

Ironwood Pharmaceuticals Initiates Apraglutide NDA Submission, Highlights Compelling New Data and Updates Corporate Structure to Position for the Future

Jan 17, 2025, 8:07 AM EST - 5 months ago

Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications

Nov 26, 2024, 4:01 PM EST - 7 months ago

Ironwood Pharmaceuticals to Participate in the Piper Sandler 36th Annual Healthcare Conference

Nov 13, 2024, 4:01 PM EST - 8 months ago

Ironwood Pharmaceuticals to Participate in the Jefferies London Healthcare Conference

Nov 7, 2024, 10:34 PM EST - 8 months ago

Ironwood Pharmaceuticals, Inc. (IRWD) Q3 2024 Earnings Call Transcript

Nov 7, 2024, 7:00 AM EST - 8 months ago

Ironwood Pharmaceuticals Reports Third Quarter 2024 Results

Oct 28, 2024, 7:00 AM EDT - 8 months ago

Once-Weekly Apraglutide Showed Consistent Treatment Effect Across Baseline Demographics and Disease Characteristics in Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF), According to New STARS Phase III Data from Ironwood at ACG 2024

Oct 24, 2024, 4:00 PM EDT - 8 months ago

Ironwood Pharmaceuticals to Host Third Quarter 2024 Investor Update Call

Aug 29, 2024, 4:01 PM EDT - 10 months ago

Ironwood Pharmaceuticals to Participate in the 2024 Wells Fargo Healthcare Conference

Aug 9, 2024, 12:10 PM EDT - 11 months ago

Ironwood Pharmaceuticals, Inc. (IRWD) Q2 2024 Earnings Call Transcript

Aug 8, 2024, 7:00 AM EDT - 11 months ago

Ironwood Pharmaceuticals Reports Second Quarter 2024 Results

Jul 25, 2024, 4:00 PM EDT - 1 year ago

Ironwood Pharmaceuticals to Host Second Quarter 2024 Investor Update Call

Jun 28, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Starts Investigation Into Claims Against Ironwood Pharmaceuticals Inc And Encourages Investors With Losses To Begin Conversation

Jun 26, 2024, 3:30 PM EDT - 1 year ago

The Schall Law Firm Initiates Inquiry Into Allegations Against Ironwood Pharmaceuticals Inc And Urges Investors Who Incurred Losses To Initiate Dialogue

Jun 25, 2024, 2:45 PM EDT - 1 year ago

The Schall Law Firm Initiates Probe Into Allegations Against Ironwood Pharmaceuticals Inc And Urges Investors Who Suffered Losses To Initiate Contact

Jun 24, 2024, 4:45 PM EDT - 1 year ago

The Schall Law Firm Begins Investigation Into Claims Against Ironwood Pharmaceuticals Inc And Encourages Investors With Losses To Establish Communication

Jun 23, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Initiates Probe Into Allegations Against Ironwood Pharmaceuticals Inc And Urges Investors With Losses To Connect

Jun 22, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Begins Investigation Into Claims Against Ironwood Pharmaceuticals Inc And Encourages Investors With Losses To Reach Out

Jun 20, 2024, 1:00 PM EDT - 1 year ago

Ironwood Pharmaceuticals: Q3 Of 2024 Data Readout For PBC

Jun 19, 2024, 4:20 PM EDT - 1 year ago

Allegations Against Ironwood Pharmaceuticals Inc The Schall Law Firm Initiates Probe And Urges Investors With Losses To Make Contact

Jun 18, 2024, 4:00 PM EDT - 1 year ago

Claims Against Ironwood Pharmaceuticals Inc The Schall Law Firm Begins Investigation And Encourages Investors With Losses To Reach Out

Jun 11, 2024, 7:00 PM EDT - 1 year ago

Claims Against Ironwood Pharmaceuticals, Inc.: The Schall Law Firm Begins Investigation And Encourages Investors With Losses To Reach Out

Jun 9, 2024, 11:00 AM EDT - 1 year ago

Claims Against Ironwood Pharmaceuticals, Inc.: The Schall Law Firm Begins Investigation And Urges Investors With Losses To Contact Them

Jun 8, 2024, 11:00 AM EDT - 1 year ago

Allegations Against Ironwood Pharmaceuticals, Inc.: The Schall Law Firm Initiates Probe And Invites Investors With Losses To Get In Touch

Jun 7, 2024, 3:00 PM EDT - 1 year ago

Claims Against Ironwood Pharmaceuticals, Inc.: The Schall Law Firm Begins Investigation And Encourages Investors With Losses To Contact Them

Jun 6, 2024, 1:00 PM EDT - 1 year ago

Accusations Against Ironwood Pharmaceuticals, Inc.: The Schall Law Firm Initiates Investigation And Invites Investors With Losses To Reach Out

Jun 5, 2024, 1:30 PM EDT - 1 year ago

Ironwood Pharmaceuticals, Inc. Accusations: Schall Law Firm Announces Investigation and Calls for Investors with Losses to Connect

Jun 4, 2024, 3:00 PM EDT - 1 year ago

The Schall Law Firm Declares an Inquiry into Accusations Against Ironwood Pharmaceuticals, Inc. and Advocates for Investors with Losses to Reach Out

Jun 2, 2024, 11:00 AM EDT - 1 year ago

ONGOING INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Ironwood Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm

May 31, 2024, 6:15 PM EDT - 1 year ago

ONGOING INVESTIGATION UPDATE: The Schall Law Firm Announces it is Investigating Claims Against Ironwood Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm

May 30, 2024, 4:01 PM EDT - 1 year ago

Ironwood Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference

May 21, 2024, 6:00 AM EDT - 1 year ago

Ironwood Late-Breaker Oral Presentation at Digestive Disease Week® Reinforces Potential of Once-Weekly Apraglutide for Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF)

May 17, 2024, 12:45 PM EDT - 1 year ago

IMPORTANT SHAREHOLDER INVESTIGATION: The Schall Law Firm Announces it is Investigating Claims Against Ironwood Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm

VSTN Jun. 26 at 5:16 PM

$IRWD Not sure where this is going, but it’s worth buying a little. At this point it can only go to zero. I don’t know what they can get for this company, if anything

0 · Reply

Green_dillo Jun. 26 at 4:15 PM

$IRWD 👀👀

0 · Reply

Peterson28 Jun. 26 at 1:40 AM

$IRWD No one is selling. Only one reason for that.

1 · Reply

BluntForceOptions Jun. 25 at 9:15 PM

$IRWD Sub-$1 sure feels like it’s on borrowed time.

0 · Reply

RunnerSignals Jun. 25 at 8:21 PM

comeback kings in action! $CTKB $CDTX $IRWD $UEC $MXCT hit lows but closed strong, proving every dip can spark a big bounce

0 · Reply

Estimize Jun. 25 at 7:05 PM

Wall St is expecting 0.04 EPS for $IRWD Q2 [Reporting 08/07 BMO] http://www.estimize.com/intro/irwd?chart=historical&metric_name=eps&utm_co

0 · Reply

valueforme Jun. 25 at 7:04 PM

$IRWD Very patient accumulation

0 · Reply

Mau74 Jun. 25 at 4:32 PM

$IRWD no volume no party

0 · Reply

Winning_calls Jun. 25 at 3:54 PM

$IRWD 😉

1 · Reply

Peterson28 Jun. 25 at 2:57 PM

$IRWD Only $100K trade for 90mins since open. What is happening?

1 · Reply

valueforme Jun. 24 at 7:43 PM

$IRWD Completed as of yesterday. As I've mentioned before it's very much related to having clean OTC label A Study to Assess Adverse Events and Change in Disease Activity in Pediatric Participants (Age 6 Months to <2 Years) With Functional Constipation Who Are Treated With Linaclotide

0 · Reply

nacho217 Jun. 24 at 5:57 PM

$IRWD 👀 shorties

0 · Reply

Mau74 Jun. 24 at 5:06 PM

$IRWD no volume never . Bah

0 · Reply

valueforme Jun. 24 at 4:02 PM

$IRWD Jana Noeldeke left Ironwood in December 2024. She had the title of "Basel Site Head & Apraglutide Lifecycle Leader". She led phase 3 of apra. She was likely been made accountable for the dosing fiasco. They started to hire the Head of Clinical Operations in Basel several weeks ago. The logic here is that no matter what happens someone needs to lead another apra phase 3. So it doesn't hurt to find tge solid candidate now

1 · Reply

ajj209 Jun. 24 at 3:14 PM

$IRWD exhausting just checking my brokerage account everyday waiting for any meaningful news here

1 · Reply

TeeMan123 Jun. 24 at 2:28 PM

$IRWD just catching up to this job posting for head of clinical operations at irwd… I guess we have to assume no bid for apra, and they are just going to recap the company by selling off linzess?

1 · Reply

Bio_Invest101 Jun. 23 at 11:06 PM

$IRWD IBO did a 340% day upon reverse merger news https://www.globenewswire.com/news-release/2025/06/23/3103299/0/en/Dr-Ashleys-Limited-and-Impact-BioMedical-Inc-Announce-Strategic-Merger.html Dr Ashleys Limited and Impact BioMedical Inc. Announce

1 · Reply

Bio_Invest101 Jun. 23 at 7:58 PM

$IRWD SI is record low now. IMO shorts anticipate news coming

1 · Reply

SwingNow Jun. 23 at 7:41 AM

$IRWD bullish here

0 · Reply

Winning_calls Jun. 23 at 4:17 AM

$IRWD pick me up @ .72

0 · Reply

buymoremakemore Jun. 20 at 9:04 PM

$IRWD If ELEV could get acquired for $0.36/sh + CVR and be completely preclinical with no revenue, theres no reason IRWD doesnt see $2 - $3 + CVR.

0 · Reply

Peterson28 Jun. 20 at 7:15 PM

$IRWD Moved some profits from SGMT here too.

0 · Reply

Market Cap	117.45M
Revenue (ttm)	351.41M
Net Income (ttm)	880,000.00
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	4.64
Profit Margin	0.25%
Debt to Equity Ratio	-1.15

Volume	1,493,221
Avg Vol	3,359,244
Day's Range	N/A - N/A
Shares Out	161.82M
Stochastic %K	93%
Beta	0.24
Analysts	Hold
Price Target	$0.92